iCAB International

🚨 PIA Group Webinar Alert 🚨 𝗥𝗲𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗔𝗥𝗜𝗔: Antibody Amplified CAA-ri? 📅 Friday, April 24, 2026 ⏰ 9:00 a.m. C.T. 💡 Join our V-PIA and don’t miss this opportunity to learn from experts and engage in cutting-edge discussion. alz-org.zoom.us/webinar/regist…

𝗜𝘀 𝗔𝗥𝗜𝗔 𝗮𝗻 𝗮𝗱𝘃𝗲𝗿𝘀𝗲 𝗲𝘃𝗲𝗻𝘁 𝗼𝗳 𝗔𝗔𝗧 𝗶𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲, 𝗼𝗿 𝘁𝗵𝗲 𝗶𝗮𝘁𝗿𝗼𝗴𝗲𝗻𝗶𝗰𝗮𝗹𝗹𝘆 𝗶𝗻𝗱𝘂𝗰𝗲𝗱 𝗺𝗮𝗻𝗶𝗳𝗲𝘀𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗖𝗔𝗔-𝗿𝗶? mdpi.com/2218-273X/16/1…

#Microbiota-gut-brain axis dysregulation in #Alzheimer’s disease and its modulation through #probiotic supplementation Fresh new published, congrats to Moira Marizzoni and many thanks to Prof. Annamaria Cattaneo and team! @iCABNetwork @alzassociation sciencedirect.com/science/articl…

#Cerebrospinal Fluid #Biomarkers Profiling in Cerebral #Amyloid Angiopathy and Relationship With Disease Phenotypes Congrats, Mattia Losa, it has been a pleasure working with you and the whole team! @iCABNetwork @alzassociation #mnesys @unimib ahajournals.org/doi/10.1161/JA…

Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes | Journal of the American Heart Association ahajournals.org/doi/10.1161/JA…

#Donanemab receives positive opinion from the European Medicine Agency Committee for Medicinal Products for Human Use (CHMP) in early symptomatic #Alzheimers disease. investor.lilly.com/news-releases/…

#Hemostasis components in cerebral #amyloid angiopathy and #Alzheimer disease Contribution of hemostasis components to Aβ deposition, endothelial and BBB dysfunction, vessel fragility, cerebral bleeding, and cognitive changes. link.springer.com/article/10.100… #donanemab #lecanemab

Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease mdpi.com/3208782 #mdpijcm via @JCM_MDPI #vascular_PIA @alzassociation #ICAAA

Comment by #European #AlzheimersDisease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of #donanemab for early Alzheimer’ s disease sciencedirect.com/science/articl… @EMA_News @alzassociation #VascularPIA @unimib

Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease sciencedirect.com/science/articl…

Cracking the code of cerebral amyloid angiopathy in AD. - Neuropathology of CAA and Its Comorbidity with AD (Prof. Jaunmuktane Z) - Rethinking ARIA in Alzheimer’s Immunotherapy: Iatrogenic CAA-ri. (Prof. Piazza F) online. Jun 13, 2025 at 4:30pm (CEST) #form" target="_blank" rel="nofollow noopener">aceglobalresearchsummit.com/?mc_cid=62e60c…

Anti-amyloid treatments, a therapeutic revolution, ready for Europe karger.com/ndd/article/do…

Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease mdpi.com/3208782 #mdpijcm

Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? mdpi.com/3257070 #mdpibiomedicines

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review mdpi.com/3255760 #mdpiapplsci via @Applsci

Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease mdpi.com/3208782 #mdpijcm

What happens in this brain of a person with fatal ARIA? We commented in @alzforum : alzforum.org/news/community…

The second autopsy report from a person who died with ARIA while on Leqembi shows severe vascular pathology similar to CAA-ri. #alzheimersdisease @VanderbiltU ow.ly/6h7550Qv3lq